nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.0607	0.118	CbGbCtD
Vardenafil—CYP3A5—Carbamazepine—epilepsy syndrome	0.0381	0.0741	CbGbCtD
Vardenafil—CYP3A5—Phenytoin—epilepsy syndrome	0.0342	0.0664	CbGbCtD
Vardenafil—CYP3A5—Phenobarbital—epilepsy syndrome	0.0305	0.0592	CbGbCtD
Vardenafil—CYP3A5—Midazolam—epilepsy syndrome	0.03	0.0584	CbGbCtD
Vardenafil—CYP3A5—Diazepam—epilepsy syndrome	0.0289	0.0561	CbGbCtD
Vardenafil—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0237	0.046	CbGbCtD
Vardenafil—CYP3A5—Valproic Acid—epilepsy syndrome	0.0228	0.0443	CbGbCtD
Vardenafil—CYP3A4—Trimethadione—epilepsy syndrome	0.022	0.0428	CbGbCtD
Vardenafil—CYP3A4—Felbamate—epilepsy syndrome	0.022	0.0428	CbGbCtD
Vardenafil—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0207	0.0402	CbGbCtD
Vardenafil—CYP3A4—Clonazepam—epilepsy syndrome	0.0187	0.0364	CbGbCtD
Vardenafil—CYP3A4—Clobazam—epilepsy syndrome	0.0179	0.0349	CbGbCtD
Vardenafil—CYP3A4—Rufinamide—epilepsy syndrome	0.0153	0.0296	CbGbCtD
Vardenafil—CYP3A4—Carbamazepine—epilepsy syndrome	0.0149	0.0289	CbGbCtD
Vardenafil—CYP3A4—Primidone—epilepsy syndrome	0.0139	0.027	CbGbCtD
Vardenafil—CYP3A4—Phenytoin—epilepsy syndrome	0.0133	0.0259	CbGbCtD
Vardenafil—CYP3A4—Propofol—epilepsy syndrome	0.0124	0.0242	CbGbCtD
Vardenafil—CYP3A4—Phenobarbital—epilepsy syndrome	0.0119	0.0231	CbGbCtD
Vardenafil—CYP3A4—Acetazolamide—epilepsy syndrome	0.0119	0.0231	CbGbCtD
Vardenafil—CYP3A4—Midazolam—epilepsy syndrome	0.0117	0.0228	CbGbCtD
Vardenafil—CYP3A4—Diazepam—epilepsy syndrome	0.0113	0.0219	CbGbCtD
Vardenafil—CYP3A4—Zonisamide—epilepsy syndrome	0.011	0.0214	CbGbCtD
Vardenafil—CYP3A4—Valproic Acid—epilepsy syndrome	0.00888	0.0173	CbGbCtD
Vardenafil—CYP3A4—Topiramate—epilepsy syndrome	0.00801	0.0156	CbGbCtD
Vardenafil—PDE10A—ganglion—epilepsy syndrome	0.00679	0.117	CbGeAlD
Vardenafil—PDE6H—forebrain—epilepsy syndrome	0.00438	0.0757	CbGeAlD
Vardenafil—PDE10A—forebrain—epilepsy syndrome	0.00285	0.0492	CbGeAlD
Vardenafil—PDE1B—forebrain—epilepsy syndrome	0.00282	0.0488	CbGeAlD
Vardenafil—PDE10A—telencephalon—epilepsy syndrome	0.00262	0.0453	CbGeAlD
Vardenafil—PDE1B—telencephalon—epilepsy syndrome	0.00259	0.0449	CbGeAlD
Vardenafil—PDE6H—head—epilepsy syndrome	0.00251	0.0434	CbGeAlD
Vardenafil—PDE6G—head—epilepsy syndrome	0.00241	0.0417	CbGeAlD
Vardenafil—PDE6H—nervous system—epilepsy syndrome	0.00238	0.0411	CbGeAlD
Vardenafil—PDE6H—central nervous system—epilepsy syndrome	0.00229	0.0396	CbGeAlD
Vardenafil—PDE11A—brain—epilepsy syndrome	0.00182	0.0314	CbGeAlD
Vardenafil—PDE6H—brain—epilepsy syndrome	0.00182	0.0314	CbGeAlD
Vardenafil—PDE5A—forebrain—epilepsy syndrome	0.00167	0.0288	CbGeAlD
Vardenafil—PDE10A—head—epilepsy syndrome	0.00163	0.0282	CbGeAlD
Vardenafil—PDE1B—head—epilepsy syndrome	0.00162	0.0279	CbGeAlD
Vardenafil—PDE10A—nervous system—epilepsy syndrome	0.00155	0.0267	CbGeAlD
Vardenafil—PDE5A—telencephalon—epilepsy syndrome	0.00153	0.0265	CbGeAlD
Vardenafil—PDE1B—nervous system—epilepsy syndrome	0.00153	0.0265	CbGeAlD
Vardenafil—PDE10A—central nervous system—epilepsy syndrome	0.00149	0.0257	CbGeAlD
Vardenafil—PDE1B—central nervous system—epilepsy syndrome	0.00147	0.0255	CbGeAlD
Vardenafil—PDE10A—cerebellum—epilepsy syndrome	0.00145	0.0252	CbGeAlD
Vardenafil—PDE1B—cerebellum—epilepsy syndrome	0.00144	0.0249	CbGeAlD
Vardenafil—PDE10A—brain—epilepsy syndrome	0.00118	0.0204	CbGeAlD
Vardenafil—PDE1B—brain—epilepsy syndrome	0.00117	0.0202	CbGeAlD
Vardenafil—PDE5A—head—epilepsy syndrome	0.000954	0.0165	CbGeAlD
Vardenafil—Sildenafil—CYP2C19—epilepsy syndrome	0.000921	0.574	CrCbGaD
Vardenafil—PDE5A—nervous system—epilepsy syndrome	0.000904	0.0156	CbGeAlD
Vardenafil—PDE5A—central nervous system—epilepsy syndrome	0.000871	0.0151	CbGeAlD
Vardenafil—PDE5A—cerebellum—epilepsy syndrome	0.000851	0.0147	CbGeAlD
Vardenafil—PDE5A—brain—epilepsy syndrome	0.000691	0.012	CbGeAlD
Vardenafil—Sildenafil—CYP2D6—epilepsy syndrome	0.000683	0.426	CrCbGaD
Vardenafil—CYP3A4—nervous system—epilepsy syndrome	0.000282	0.00488	CbGeAlD
Vardenafil—CYP3A4—central nervous system—epilepsy syndrome	0.000271	0.00469	CbGeAlD
Vardenafil—Rash—Fosphenytoin—epilepsy syndrome	9.47e-05	0.000325	CcSEcCtD
Vardenafil—Dermatitis—Fosphenytoin—epilepsy syndrome	9.46e-05	0.000325	CcSEcCtD
Vardenafil—Haemoglobin—Topiramate—epilepsy syndrome	9.45e-05	0.000325	CcSEcCtD
Vardenafil—Asthenia—Clonazepam—epilepsy syndrome	9.44e-05	0.000325	CcSEcCtD
Vardenafil—Rhinitis—Topiramate—epilepsy syndrome	9.43e-05	0.000324	CcSEcCtD
Vardenafil—Back pain—Gabapentin—epilepsy syndrome	9.41e-05	0.000324	CcSEcCtD
Vardenafil—Headache—Fosphenytoin—epilepsy syndrome	9.41e-05	0.000323	CcSEcCtD
Vardenafil—Haemorrhage—Topiramate—epilepsy syndrome	9.4e-05	0.000323	CcSEcCtD
Vardenafil—Nervous system disorder—Valproic Acid—epilepsy syndrome	9.39e-05	0.000323	CcSEcCtD
Vardenafil—Palpitations—Pregabalin—epilepsy syndrome	9.38e-05	0.000322	CcSEcCtD
Vardenafil—Asthenia—Phenytoin—epilepsy syndrome	9.38e-05	0.000322	CcSEcCtD
Vardenafil—Nausea—Midazolam—epilepsy syndrome	9.36e-05	0.000322	CcSEcCtD
Vardenafil—Hypoaesthesia—Topiramate—epilepsy syndrome	9.36e-05	0.000322	CcSEcCtD
Vardenafil—Muscle spasms—Gabapentin—epilepsy syndrome	9.36e-05	0.000322	CcSEcCtD
Vardenafil—Tachycardia—Valproic Acid—epilepsy syndrome	9.35e-05	0.000321	CcSEcCtD
Vardenafil—Diarrhoea—Zonisamide—epilepsy syndrome	9.34e-05	0.000321	CcSEcCtD
Vardenafil—Pharyngitis—Topiramate—epilepsy syndrome	9.33e-05	0.000321	CcSEcCtD
Vardenafil—Loss of consciousness—Pregabalin—epilepsy syndrome	9.33e-05	0.000321	CcSEcCtD
Vardenafil—Asthenia—Oxcarbazepine—epilepsy syndrome	9.33e-05	0.000321	CcSEcCtD
Vardenafil—Pruritus—Clonazepam—epilepsy syndrome	9.31e-05	0.00032	CcSEcCtD
Vardenafil—Vomiting—Vigabatrin—epilepsy syndrome	9.31e-05	0.00032	CcSEcCtD
Vardenafil—Skin disorder—Valproic Acid—epilepsy syndrome	9.31e-05	0.00032	CcSEcCtD
Vardenafil—Urinary tract disorder—Topiramate—epilepsy syndrome	9.29e-05	0.000319	CcSEcCtD
Vardenafil—Hyperhidrosis—Valproic Acid—epilepsy syndrome	9.26e-05	0.000318	CcSEcCtD
Vardenafil—Pruritus—Phenytoin—epilepsy syndrome	9.25e-05	0.000318	CcSEcCtD
Vardenafil—Connective tissue disorder—Topiramate—epilepsy syndrome	9.24e-05	0.000318	CcSEcCtD
Vardenafil—Nausea—Levetiracetam—epilepsy syndrome	9.24e-05	0.000318	CcSEcCtD
Vardenafil—Rash—Vigabatrin—epilepsy syndrome	9.23e-05	0.000317	CcSEcCtD
Vardenafil—Dizziness—Felbamate—epilepsy syndrome	9.22e-05	0.000317	CcSEcCtD
Vardenafil—Dermatitis—Vigabatrin—epilepsy syndrome	9.22e-05	0.000317	CcSEcCtD
Vardenafil—Urethral disorder—Topiramate—epilepsy syndrome	9.22e-05	0.000317	CcSEcCtD
Vardenafil—Pruritus—Oxcarbazepine—epilepsy syndrome	9.2e-05	0.000316	CcSEcCtD
Vardenafil—Convulsion—Pregabalin—epilepsy syndrome	9.19e-05	0.000316	CcSEcCtD
Vardenafil—Hypersensitivity—Carbamazepine—epilepsy syndrome	9.19e-05	0.000316	CcSEcCtD
Vardenafil—Vision blurred—Gabapentin—epilepsy syndrome	9.17e-05	0.000315	CcSEcCtD
Vardenafil—Headache—Vigabatrin—epilepsy syndrome	9.17e-05	0.000315	CcSEcCtD
Vardenafil—Vomiting—Diazepam—epilepsy syndrome	9.16e-05	0.000315	CcSEcCtD
Vardenafil—Rash—Diazepam—epilepsy syndrome	9.08e-05	0.000312	CcSEcCtD
Vardenafil—Dermatitis—Diazepam—epilepsy syndrome	9.08e-05	0.000312	CcSEcCtD
Vardenafil—Visual impairment—Topiramate—epilepsy syndrome	9.06e-05	0.000312	CcSEcCtD
Vardenafil—Arthralgia—Pregabalin—epilepsy syndrome	9.03e-05	0.000311	CcSEcCtD
Vardenafil—Chest pain—Pregabalin—epilepsy syndrome	9.03e-05	0.000311	CcSEcCtD
Vardenafil—Myalgia—Pregabalin—epilepsy syndrome	9.03e-05	0.000311	CcSEcCtD
Vardenafil—Ill-defined disorder—Gabapentin—epilepsy syndrome	9.03e-05	0.00031	CcSEcCtD
Vardenafil—Dizziness—Zonisamide—epilepsy syndrome	9.03e-05	0.00031	CcSEcCtD
Vardenafil—Headache—Diazepam—epilepsy syndrome	9.03e-05	0.00031	CcSEcCtD
Vardenafil—Anxiety—Pregabalin—epilepsy syndrome	9e-05	0.00031	CcSEcCtD
Vardenafil—Diarrhoea—Clonazepam—epilepsy syndrome	9e-05	0.000309	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	8.97e-05	0.000308	CcSEcCtD
Vardenafil—Hypotension—Valproic Acid—epilepsy syndrome	8.95e-05	0.000308	CcSEcCtD
Vardenafil—Asthenia—Carbamazepine—epilepsy syndrome	8.95e-05	0.000308	CcSEcCtD
Vardenafil—Diarrhoea—Phenytoin—epilepsy syndrome	8.94e-05	0.000307	CcSEcCtD
Vardenafil—Discomfort—Pregabalin—epilepsy syndrome	8.93e-05	0.000307	CcSEcCtD
Vardenafil—Nausea—Fosphenytoin—epilepsy syndrome	8.92e-05	0.000307	CcSEcCtD
Vardenafil—Diarrhoea—Oxcarbazepine—epilepsy syndrome	8.89e-05	0.000306	CcSEcCtD
Vardenafil—Angioedema—Gabapentin—epilepsy syndrome	8.89e-05	0.000306	CcSEcCtD
Vardenafil—Hypersensitivity—Lamotrigine—epilepsy syndrome	8.88e-05	0.000305	CcSEcCtD
Vardenafil—Vomiting—Felbamate—epilepsy syndrome	8.87e-05	0.000305	CcSEcCtD
Vardenafil—Dry mouth—Pregabalin—epilepsy syndrome	8.84e-05	0.000304	CcSEcCtD
Vardenafil—Pruritus—Carbamazepine—epilepsy syndrome	8.83e-05	0.000303	CcSEcCtD
Vardenafil—Rash—Felbamate—epilepsy syndrome	8.79e-05	0.000302	CcSEcCtD
Vardenafil—Eye disorder—Topiramate—epilepsy syndrome	8.79e-05	0.000302	CcSEcCtD
Vardenafil—Dermatitis—Felbamate—epilepsy syndrome	8.78e-05	0.000302	CcSEcCtD
Vardenafil—Malaise—Gabapentin—epilepsy syndrome	8.78e-05	0.000302	CcSEcCtD
Vardenafil—Tinnitus—Topiramate—epilepsy syndrome	8.77e-05	0.000301	CcSEcCtD
Vardenafil—Vertigo—Gabapentin—epilepsy syndrome	8.74e-05	0.000301	CcSEcCtD
Vardenafil—Headache—Felbamate—epilepsy syndrome	8.74e-05	0.0003	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	8.73e-05	0.0003	CcSEcCtD
Vardenafil—Cardiac disorder—Topiramate—epilepsy syndrome	8.73e-05	0.0003	CcSEcCtD
Vardenafil—Flushing—Topiramate—epilepsy syndrome	8.73e-05	0.0003	CcSEcCtD
Vardenafil—Syncope—Gabapentin—epilepsy syndrome	8.73e-05	0.0003	CcSEcCtD
Vardenafil—Dizziness—Clonazepam—epilepsy syndrome	8.7e-05	0.000299	CcSEcCtD
Vardenafil—Nausea—Vigabatrin—epilepsy syndrome	8.69e-05	0.000299	CcSEcCtD
Vardenafil—Vomiting—Zonisamide—epilepsy syndrome	8.68e-05	0.000298	CcSEcCtD
Vardenafil—Insomnia—Valproic Acid—epilepsy syndrome	8.66e-05	0.000298	CcSEcCtD
Vardenafil—Anaphylactic shock—Pregabalin—epilepsy syndrome	8.66e-05	0.000298	CcSEcCtD
Vardenafil—Asthenia—Lamotrigine—epilepsy syndrome	8.65e-05	0.000297	CcSEcCtD
Vardenafil—Dizziness—Phenytoin—epilepsy syndrome	8.64e-05	0.000297	CcSEcCtD
Vardenafil—Rash—Zonisamide—epilepsy syndrome	8.61e-05	0.000296	CcSEcCtD
Vardenafil—Infection—Pregabalin—epilepsy syndrome	8.6e-05	0.000296	CcSEcCtD
Vardenafil—Paraesthesia—Valproic Acid—epilepsy syndrome	8.6e-05	0.000296	CcSEcCtD
Vardenafil—Palpitations—Gabapentin—epilepsy syndrome	8.6e-05	0.000296	CcSEcCtD
Vardenafil—Dermatitis—Zonisamide—epilepsy syndrome	8.6e-05	0.000296	CcSEcCtD
Vardenafil—Dizziness—Oxcarbazepine—epilepsy syndrome	8.6e-05	0.000296	CcSEcCtD
Vardenafil—Nausea—Diazepam—epilepsy syndrome	8.56e-05	0.000294	CcSEcCtD
Vardenafil—Loss of consciousness—Gabapentin—epilepsy syndrome	8.55e-05	0.000294	CcSEcCtD
Vardenafil—Headache—Zonisamide—epilepsy syndrome	8.55e-05	0.000294	CcSEcCtD
Vardenafil—Dyspnoea—Valproic Acid—epilepsy syndrome	8.54e-05	0.000294	CcSEcCtD
Vardenafil—Diarrhoea—Carbamazepine—epilepsy syndrome	8.53e-05	0.000293	CcSEcCtD
Vardenafil—Angiopathy—Topiramate—epilepsy syndrome	8.53e-05	0.000293	CcSEcCtD
Vardenafil—Pruritus—Lamotrigine—epilepsy syndrome	8.53e-05	0.000293	CcSEcCtD
Vardenafil—Shock—Pregabalin—epilepsy syndrome	8.52e-05	0.000293	CcSEcCtD
Vardenafil—Somnolence—Valproic Acid—epilepsy syndrome	8.52e-05	0.000293	CcSEcCtD
Vardenafil—Immune system disorder—Topiramate—epilepsy syndrome	8.49e-05	0.000292	CcSEcCtD
Vardenafil—Nervous system disorder—Pregabalin—epilepsy syndrome	8.49e-05	0.000292	CcSEcCtD
Vardenafil—Mediastinal disorder—Topiramate—epilepsy syndrome	8.48e-05	0.000291	CcSEcCtD
Vardenafil—Tachycardia—Pregabalin—epilepsy syndrome	8.45e-05	0.000291	CcSEcCtD
Vardenafil—Dyspepsia—Valproic Acid—epilepsy syndrome	8.43e-05	0.00029	CcSEcCtD
Vardenafil—Convulsion—Gabapentin—epilepsy syndrome	8.43e-05	0.00029	CcSEcCtD
Vardenafil—Skin disorder—Pregabalin—epilepsy syndrome	8.41e-05	0.000289	CcSEcCtD
Vardenafil—Hyperhidrosis—Pregabalin—epilepsy syndrome	8.37e-05	0.000288	CcSEcCtD
Vardenafil—Vomiting—Clonazepam—epilepsy syndrome	8.36e-05	0.000288	CcSEcCtD
Vardenafil—Vomiting—Phenytoin—epilepsy syndrome	8.31e-05	0.000286	CcSEcCtD
Vardenafil—Rash—Clonazepam—epilepsy syndrome	8.3e-05	0.000285	CcSEcCtD
Vardenafil—Dermatitis—Clonazepam—epilepsy syndrome	8.29e-05	0.000285	CcSEcCtD
Vardenafil—Myalgia—Gabapentin—epilepsy syndrome	8.28e-05	0.000285	CcSEcCtD
Vardenafil—Arthralgia—Gabapentin—epilepsy syndrome	8.28e-05	0.000285	CcSEcCtD
Vardenafil—Chest pain—Gabapentin—epilepsy syndrome	8.28e-05	0.000285	CcSEcCtD
Vardenafil—Nausea—Felbamate—epilepsy syndrome	8.28e-05	0.000285	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	8.27e-05	0.000284	CcSEcCtD
Vardenafil—Vomiting—Oxcarbazepine—epilepsy syndrome	8.26e-05	0.000284	CcSEcCtD
Vardenafil—Anxiety—Gabapentin—epilepsy syndrome	8.26e-05	0.000284	CcSEcCtD
Vardenafil—Dizziness—Carbamazepine—epilepsy syndrome	8.25e-05	0.000284	CcSEcCtD
Vardenafil—Diarrhoea—Lamotrigine—epilepsy syndrome	8.25e-05	0.000284	CcSEcCtD
Vardenafil—Headache—Clonazepam—epilepsy syndrome	8.24e-05	0.000283	CcSEcCtD
Vardenafil—Rash—Phenytoin—epilepsy syndrome	8.24e-05	0.000283	CcSEcCtD
Vardenafil—Mental disorder—Topiramate—epilepsy syndrome	8.24e-05	0.000283	CcSEcCtD
Vardenafil—Dermatitis—Phenytoin—epilepsy syndrome	8.23e-05	0.000283	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	8.23e-05	0.000283	CcSEcCtD
Vardenafil—Rash—Oxcarbazepine—epilepsy syndrome	8.2e-05	0.000282	CcSEcCtD
Vardenafil—Pain—Valproic Acid—epilepsy syndrome	8.19e-05	0.000282	CcSEcCtD
Vardenafil—Dermatitis—Oxcarbazepine—epilepsy syndrome	8.19e-05	0.000282	CcSEcCtD
Vardenafil—Headache—Phenytoin—epilepsy syndrome	8.19e-05	0.000281	CcSEcCtD
Vardenafil—Erythema—Topiramate—epilepsy syndrome	8.19e-05	0.000281	CcSEcCtD
Vardenafil—Discomfort—Gabapentin—epilepsy syndrome	8.19e-05	0.000281	CcSEcCtD
Vardenafil—Headache—Oxcarbazepine—epilepsy syndrome	8.14e-05	0.00028	CcSEcCtD
Vardenafil—Nausea—Zonisamide—epilepsy syndrome	8.11e-05	0.000279	CcSEcCtD
Vardenafil—Dry mouth—Gabapentin—epilepsy syndrome	8.1e-05	0.000279	CcSEcCtD
Vardenafil—Hypotension—Pregabalin—epilepsy syndrome	8.09e-05	0.000278	CcSEcCtD
Vardenafil—Dizziness—Lamotrigine—epilepsy syndrome	7.97e-05	0.000274	CcSEcCtD
Vardenafil—Anaphylactic shock—Gabapentin—epilepsy syndrome	7.94e-05	0.000273	CcSEcCtD
Vardenafil—Vomiting—Carbamazepine—epilepsy syndrome	7.93e-05	0.000273	CcSEcCtD
Vardenafil—Back pain—Topiramate—epilepsy syndrome	7.92e-05	0.000272	CcSEcCtD
Vardenafil—Feeling abnormal—Valproic Acid—epilepsy syndrome	7.89e-05	0.000271	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	7.89e-05	0.000271	CcSEcCtD
Vardenafil—Infection—Gabapentin—epilepsy syndrome	7.89e-05	0.000271	CcSEcCtD
Vardenafil—Muscle spasms—Topiramate—epilepsy syndrome	7.87e-05	0.000271	CcSEcCtD
Vardenafil—Rash—Carbamazepine—epilepsy syndrome	7.86e-05	0.00027	CcSEcCtD
Vardenafil—Dermatitis—Carbamazepine—epilepsy syndrome	7.86e-05	0.00027	CcSEcCtD
Vardenafil—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	7.83e-05	0.000269	CcSEcCtD
Vardenafil—Insomnia—Pregabalin—epilepsy syndrome	7.83e-05	0.000269	CcSEcCtD
Vardenafil—Nausea—Clonazepam—epilepsy syndrome	7.81e-05	0.000269	CcSEcCtD
Vardenafil—Headache—Carbamazepine—epilepsy syndrome	7.81e-05	0.000269	CcSEcCtD
Vardenafil—Shock—Gabapentin—epilepsy syndrome	7.81e-05	0.000269	CcSEcCtD
Vardenafil—Nervous system disorder—Gabapentin—epilepsy syndrome	7.79e-05	0.000268	CcSEcCtD
Vardenafil—Paraesthesia—Pregabalin—epilepsy syndrome	7.78e-05	0.000267	CcSEcCtD
Vardenafil—Nausea—Phenytoin—epilepsy syndrome	7.76e-05	0.000267	CcSEcCtD
Vardenafil—Tachycardia—Gabapentin—epilepsy syndrome	7.75e-05	0.000266	CcSEcCtD
Vardenafil—Dyspnoea—Pregabalin—epilepsy syndrome	7.72e-05	0.000265	CcSEcCtD
Vardenafil—Nausea—Oxcarbazepine—epilepsy syndrome	7.72e-05	0.000265	CcSEcCtD
Vardenafil—Vision blurred—Topiramate—epilepsy syndrome	7.72e-05	0.000265	CcSEcCtD
Vardenafil—Skin disorder—Gabapentin—epilepsy syndrome	7.71e-05	0.000265	CcSEcCtD
Vardenafil—Somnolence—Pregabalin—epilepsy syndrome	7.7e-05	0.000265	CcSEcCtD
Vardenafil—Hyperhidrosis—Gabapentin—epilepsy syndrome	7.68e-05	0.000264	CcSEcCtD
Vardenafil—Vomiting—Lamotrigine—epilepsy syndrome	7.67e-05	0.000264	CcSEcCtD
Vardenafil—Rash—Lamotrigine—epilepsy syndrome	7.6e-05	0.000261	CcSEcCtD
Vardenafil—Ill-defined disorder—Topiramate—epilepsy syndrome	7.6e-05	0.000261	CcSEcCtD
Vardenafil—Dermatitis—Lamotrigine—epilepsy syndrome	7.59e-05	0.000261	CcSEcCtD
Vardenafil—Abdominal pain—Valproic Acid—epilepsy syndrome	7.57e-05	0.00026	CcSEcCtD
Vardenafil—Headache—Lamotrigine—epilepsy syndrome	7.55e-05	0.00026	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	7.48e-05	0.000257	CcSEcCtD
Vardenafil—Hypotension—Gabapentin—epilepsy syndrome	7.42e-05	0.000255	CcSEcCtD
Vardenafil—Nausea—Carbamazepine—epilepsy syndrome	7.41e-05	0.000255	CcSEcCtD
Vardenafil—Pain—Pregabalin—epilepsy syndrome	7.41e-05	0.000255	CcSEcCtD
Vardenafil—Malaise—Topiramate—epilepsy syndrome	7.38e-05	0.000254	CcSEcCtD
Vardenafil—Vertigo—Topiramate—epilepsy syndrome	7.36e-05	0.000253	CcSEcCtD
Vardenafil—Syncope—Topiramate—epilepsy syndrome	7.34e-05	0.000252	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	7.24e-05	0.000249	CcSEcCtD
Vardenafil—Palpitations—Topiramate—epilepsy syndrome	7.23e-05	0.000249	CcSEcCtD
Vardenafil—Loss of consciousness—Topiramate—epilepsy syndrome	7.2e-05	0.000247	CcSEcCtD
Vardenafil—Insomnia—Gabapentin—epilepsy syndrome	7.18e-05	0.000247	CcSEcCtD
Vardenafil—Nausea—Lamotrigine—epilepsy syndrome	7.16e-05	0.000246	CcSEcCtD
Vardenafil—Feeling abnormal—Pregabalin—epilepsy syndrome	7.14e-05	0.000245	CcSEcCtD
Vardenafil—Paraesthesia—Gabapentin—epilepsy syndrome	7.13e-05	0.000245	CcSEcCtD
Vardenafil—Convulsion—Topiramate—epilepsy syndrome	7.09e-05	0.000244	CcSEcCtD
Vardenafil—Gastrointestinal pain—Pregabalin—epilepsy syndrome	7.08e-05	0.000243	CcSEcCtD
Vardenafil—Dyspnoea—Gabapentin—epilepsy syndrome	7.08e-05	0.000243	CcSEcCtD
Vardenafil—Somnolence—Gabapentin—epilepsy syndrome	7.06e-05	0.000243	CcSEcCtD
Vardenafil—Hypersensitivity—Valproic Acid—epilepsy syndrome	7.06e-05	0.000243	CcSEcCtD
Vardenafil—Dyspepsia—Gabapentin—epilepsy syndrome	6.99e-05	0.00024	CcSEcCtD
Vardenafil—Chest pain—Topiramate—epilepsy syndrome	6.97e-05	0.00024	CcSEcCtD
Vardenafil—Myalgia—Topiramate—epilepsy syndrome	6.97e-05	0.00024	CcSEcCtD
Vardenafil—Arthralgia—Topiramate—epilepsy syndrome	6.97e-05	0.00024	CcSEcCtD
Vardenafil—Anxiety—Topiramate—epilepsy syndrome	6.95e-05	0.000239	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	6.92e-05	0.000238	CcSEcCtD
Vardenafil—Discomfort—Topiramate—epilepsy syndrome	6.89e-05	0.000237	CcSEcCtD
Vardenafil—Asthenia—Valproic Acid—epilepsy syndrome	6.87e-05	0.000236	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	6.86e-05	0.000236	CcSEcCtD
Vardenafil—Abdominal pain—Pregabalin—epilepsy syndrome	6.85e-05	0.000235	CcSEcCtD
Vardenafil—Dry mouth—Topiramate—epilepsy syndrome	6.82e-05	0.000234	CcSEcCtD
Vardenafil—Pain—Gabapentin—epilepsy syndrome	6.79e-05	0.000233	CcSEcCtD
Vardenafil—Pruritus—Valproic Acid—epilepsy syndrome	6.78e-05	0.000233	CcSEcCtD
Vardenafil—Infection—Topiramate—epilepsy syndrome	6.64e-05	0.000228	CcSEcCtD
Vardenafil—Shock—Topiramate—epilepsy syndrome	6.57e-05	0.000226	CcSEcCtD
Vardenafil—Diarrhoea—Valproic Acid—epilepsy syndrome	6.55e-05	0.000225	CcSEcCtD
Vardenafil—Nervous system disorder—Topiramate—epilepsy syndrome	6.55e-05	0.000225	CcSEcCtD
Vardenafil—Feeling abnormal—Gabapentin—epilepsy syndrome	6.54e-05	0.000225	CcSEcCtD
Vardenafil—Tachycardia—Topiramate—epilepsy syndrome	6.52e-05	0.000224	CcSEcCtD
Vardenafil—Gastrointestinal pain—Gabapentin—epilepsy syndrome	6.49e-05	0.000223	CcSEcCtD
Vardenafil—Skin disorder—Topiramate—epilepsy syndrome	6.49e-05	0.000223	CcSEcCtD
Vardenafil—Hyperhidrosis—Topiramate—epilepsy syndrome	6.46e-05	0.000222	CcSEcCtD
Vardenafil—Hypersensitivity—Pregabalin—epilepsy syndrome	6.38e-05	0.000219	CcSEcCtD
Vardenafil—Dizziness—Valproic Acid—epilepsy syndrome	6.33e-05	0.000218	CcSEcCtD
Vardenafil—Abdominal pain—Gabapentin—epilepsy syndrome	6.28e-05	0.000216	CcSEcCtD
Vardenafil—Hypotension—Topiramate—epilepsy syndrome	6.24e-05	0.000215	CcSEcCtD
Vardenafil—Asthenia—Pregabalin—epilepsy syndrome	6.21e-05	0.000214	CcSEcCtD
Vardenafil—Pruritus—Pregabalin—epilepsy syndrome	6.13e-05	0.000211	CcSEcCtD
Vardenafil—Vomiting—Valproic Acid—epilepsy syndrome	6.09e-05	0.000209	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	6.09e-05	0.000209	CcSEcCtD
Vardenafil—Insomnia—Topiramate—epilepsy syndrome	6.04e-05	0.000208	CcSEcCtD
Vardenafil—Rash—Valproic Acid—epilepsy syndrome	6.04e-05	0.000208	CcSEcCtD
Vardenafil—Dermatitis—Valproic Acid—epilepsy syndrome	6.03e-05	0.000207	CcSEcCtD
Vardenafil—Headache—Valproic Acid—epilepsy syndrome	6e-05	0.000206	CcSEcCtD
Vardenafil—Paraesthesia—Topiramate—epilepsy syndrome	6e-05	0.000206	CcSEcCtD
Vardenafil—Dyspnoea—Topiramate—epilepsy syndrome	5.96e-05	0.000205	CcSEcCtD
Vardenafil—Somnolence—Topiramate—epilepsy syndrome	5.94e-05	0.000204	CcSEcCtD
Vardenafil—Diarrhoea—Pregabalin—epilepsy syndrome	5.93e-05	0.000204	CcSEcCtD
Vardenafil—Dyspepsia—Topiramate—epilepsy syndrome	5.88e-05	0.000202	CcSEcCtD
Vardenafil—Hypersensitivity—Gabapentin—epilepsy syndrome	5.85e-05	0.000201	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.77e-05	0.000198	CcSEcCtD
Vardenafil—Dizziness—Pregabalin—epilepsy syndrome	5.73e-05	0.000197	CcSEcCtD
Vardenafil—Pain—Topiramate—epilepsy syndrome	5.71e-05	0.000196	CcSEcCtD
Vardenafil—Asthenia—Gabapentin—epilepsy syndrome	5.7e-05	0.000196	CcSEcCtD
Vardenafil—Nausea—Valproic Acid—epilepsy syndrome	5.69e-05	0.000196	CcSEcCtD
Vardenafil—Pruritus—Gabapentin—epilepsy syndrome	5.62e-05	0.000193	CcSEcCtD
Vardenafil—Vomiting—Pregabalin—epilepsy syndrome	5.51e-05	0.000189	CcSEcCtD
Vardenafil—Feeling abnormal—Topiramate—epilepsy syndrome	5.51e-05	0.000189	CcSEcCtD
Vardenafil—Gastrointestinal pain—Topiramate—epilepsy syndrome	5.46e-05	0.000188	CcSEcCtD
Vardenafil—Rash—Pregabalin—epilepsy syndrome	5.46e-05	0.000188	CcSEcCtD
Vardenafil—Dermatitis—Pregabalin—epilepsy syndrome	5.46e-05	0.000188	CcSEcCtD
Vardenafil—Diarrhoea—Gabapentin—epilepsy syndrome	5.43e-05	0.000187	CcSEcCtD
Vardenafil—Headache—Pregabalin—epilepsy syndrome	5.43e-05	0.000187	CcSEcCtD
Vardenafil—Abdominal pain—Topiramate—epilepsy syndrome	5.28e-05	0.000182	CcSEcCtD
Vardenafil—Dizziness—Gabapentin—epilepsy syndrome	5.25e-05	0.000181	CcSEcCtD
Vardenafil—Nausea—Pregabalin—epilepsy syndrome	5.14e-05	0.000177	CcSEcCtD
Vardenafil—Vomiting—Gabapentin—epilepsy syndrome	5.05e-05	0.000174	CcSEcCtD
Vardenafil—Rash—Gabapentin—epilepsy syndrome	5.01e-05	0.000172	CcSEcCtD
Vardenafil—Dermatitis—Gabapentin—epilepsy syndrome	5e-05	0.000172	CcSEcCtD
Vardenafil—Headache—Gabapentin—epilepsy syndrome	4.98e-05	0.000171	CcSEcCtD
Vardenafil—Hypersensitivity—Topiramate—epilepsy syndrome	4.92e-05	0.000169	CcSEcCtD
Vardenafil—Asthenia—Topiramate—epilepsy syndrome	4.79e-05	0.000165	CcSEcCtD
Vardenafil—Pruritus—Topiramate—epilepsy syndrome	4.73e-05	0.000163	CcSEcCtD
Vardenafil—Nausea—Gabapentin—epilepsy syndrome	4.72e-05	0.000162	CcSEcCtD
Vardenafil—Diarrhoea—Topiramate—epilepsy syndrome	4.57e-05	0.000157	CcSEcCtD
Vardenafil—Dizziness—Topiramate—epilepsy syndrome	4.42e-05	0.000152	CcSEcCtD
Vardenafil—Vomiting—Topiramate—epilepsy syndrome	4.25e-05	0.000146	CcSEcCtD
Vardenafil—Rash—Topiramate—epilepsy syndrome	4.21e-05	0.000145	CcSEcCtD
Vardenafil—Dermatitis—Topiramate—epilepsy syndrome	4.21e-05	0.000145	CcSEcCtD
Vardenafil—Headache—Topiramate—epilepsy syndrome	4.19e-05	0.000144	CcSEcCtD
Vardenafil—Nausea—Topiramate—epilepsy syndrome	3.97e-05	0.000136	CcSEcCtD
Vardenafil—CYP3A5—Metabolism—NEU1—epilepsy syndrome	2.22e-05	0.000164	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—UPB1—epilepsy syndrome	2.22e-05	0.000164	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ATIC—epilepsy syndrome	2.22e-05	0.000164	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NPY—epilepsy syndrome	2.21e-05	0.000164	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ATP2A2—epilepsy syndrome	2.21e-05	0.000164	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—KDR—epilepsy syndrome	2.19e-05	0.000162	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—BCL2—epilepsy syndrome	2.17e-05	0.00016	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PRKCB—epilepsy syndrome	2.16e-05	0.00016	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CDC42—epilepsy syndrome	2.16e-05	0.00016	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—AGT—epilepsy syndrome	2.15e-05	0.000159	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—POMC—epilepsy syndrome	2.15e-05	0.000159	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IL6ST—epilepsy syndrome	2.15e-05	0.000159	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL18—epilepsy syndrome	2.14e-05	0.000158	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HSPB1—epilepsy syndrome	2.14e-05	0.000158	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CXCL2—epilepsy syndrome	2.14e-05	0.000158	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—OXT—epilepsy syndrome	2.14e-05	0.000158	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CRH—epilepsy syndrome	2.14e-05	0.000158	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCL3—epilepsy syndrome	2.14e-05	0.000158	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—HSD17B4—epilepsy syndrome	2.13e-05	0.000158	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—RELA—epilepsy syndrome	2.12e-05	0.000157	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PRKCB—epilepsy syndrome	2.11e-05	0.000156	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CCL2—epilepsy syndrome	2.11e-05	0.000156	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CCR5—epilepsy syndrome	2.11e-05	0.000156	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IL6ST—epilepsy syndrome	2.1e-05	0.000155	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—FYN—epilepsy syndrome	2.08e-05	0.000154	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—MTOR—epilepsy syndrome	2.08e-05	0.000154	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MEF2C—epilepsy syndrome	2.07e-05	0.000153	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—HTR2A—epilepsy syndrome	2.06e-05	0.000153	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PPP1R3C—epilepsy syndrome	2.06e-05	0.000152	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GBE1—epilepsy syndrome	2.06e-05	0.000152	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—YWHAZ—epilepsy syndrome	2e-05	0.000148	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.99e-05	0.000147	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PTK2B—epilepsy syndrome	1.99e-05	0.000147	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TSC1—epilepsy syndrome	1.99e-05	0.000147	CbGpPWpGaD
Vardenafil—PDE1B—Disease—HES1—epilepsy syndrome	1.98e-05	0.000146	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—POMC—epilepsy syndrome	1.97e-05	0.000146	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.96e-05	0.000145	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—AGT—epilepsy syndrome	1.96e-05	0.000145	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ASAH1—epilepsy syndrome	1.94e-05	0.000143	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NTRK2—epilepsy syndrome	1.93e-05	0.000143	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SST—epilepsy syndrome	1.93e-05	0.000143	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCR2—epilepsy syndrome	1.93e-05	0.000143	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CCL2—epilepsy syndrome	1.93e-05	0.000143	CbGpPWpGaD
Vardenafil—PDE1B—Disease—FYN—epilepsy syndrome	1.92e-05	0.000142	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—POMC—epilepsy syndrome	1.92e-05	0.000142	CbGpPWpGaD
Vardenafil—PDE1B—Disease—H2AFX—epilepsy syndrome	1.92e-05	0.000142	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—DUSP6—epilepsy syndrome	1.91e-05	0.000142	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—FGF2—epilepsy syndrome	1.9e-05	0.000141	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ADRA2A—epilepsy syndrome	1.89e-05	0.00014	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—STXBP1—epilepsy syndrome	1.88e-05	0.000139	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PLAT—epilepsy syndrome	1.88e-05	0.000139	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CCL2—epilepsy syndrome	1.88e-05	0.000139	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—JUN—epilepsy syndrome	1.86e-05	0.000137	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—SRC—epilepsy syndrome	1.85e-05	0.000137	CbGpPWpGaD
Vardenafil—PDE1B—Disease—YWHAZ—epilepsy syndrome	1.85e-05	0.000137	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NT5E—epilepsy syndrome	1.84e-05	0.000136	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ALAD—epilepsy syndrome	1.84e-05	0.000136	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CXCL12—epilepsy syndrome	1.82e-05	0.000134	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—BDKRB2—epilepsy syndrome	1.82e-05	0.000134	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—AKT1—epilepsy syndrome	1.82e-05	0.000134	CbGpPWpGaD
Vardenafil—PDE6G—Disease—SRC—epilepsy syndrome	1.81e-05	0.000134	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—POMC—epilepsy syndrome	1.81e-05	0.000134	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PRKCB—epilepsy syndrome	1.81e-05	0.000134	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—VEGFA—epilepsy syndrome	1.8e-05	0.000133	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—IL6ST—epilepsy syndrome	1.8e-05	0.000133	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—TSC2—epilepsy syndrome	1.79e-05	0.000132	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CRP—epilepsy syndrome	1.79e-05	0.000132	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—JUNB—epilepsy syndrome	1.78e-05	0.000132	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CNR1—epilepsy syndrome	1.78e-05	0.000132	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CCR5—epilepsy syndrome	1.78e-05	0.000132	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PLCB1—epilepsy syndrome	1.78e-05	0.000131	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—RELA—epilepsy syndrome	1.77e-05	0.000131	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ALDH7A1—epilepsy syndrome	1.75e-05	0.00013	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CACNA1A—epilepsy syndrome	1.75e-05	0.00013	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—FGF2—epilepsy syndrome	1.74e-05	0.000129	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HTR7—epilepsy syndrome	1.74e-05	0.000129	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MTOR—epilepsy syndrome	1.73e-05	0.000128	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ST3GAL3—epilepsy syndrome	1.71e-05	0.000127	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—FGF2—epilepsy syndrome	1.7e-05	0.000126	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HBEGF—epilepsy syndrome	1.69e-05	0.000125	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ADSL—epilepsy syndrome	1.68e-05	0.000124	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—SRC—epilepsy syndrome	1.67e-05	0.000123	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AKT3—epilepsy syndrome	1.66e-05	0.000123	CbGpPWpGaD
Vardenafil—PDE1B—Disease—TSC2—epilepsy syndrome	1.65e-05	0.000122	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PRKCB—epilepsy syndrome	1.65e-05	0.000122	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—POMC—epilepsy syndrome	1.65e-05	0.000122	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GLUL—epilepsy syndrome	1.65e-05	0.000122	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL6ST—epilepsy syndrome	1.65e-05	0.000122	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ADAM10—epilepsy syndrome	1.62e-05	0.00012	CbGpPWpGaD
Vardenafil—PDE1B—Disease—APOE—epilepsy syndrome	1.62e-05	0.00012	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—RELA—epilepsy syndrome	1.62e-05	0.00012	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CACNA1D—epilepsy syndrome	1.62e-05	0.00012	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CCL2—epilepsy syndrome	1.61e-05	0.000119	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.61e-05	0.000119	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CASP3—epilepsy syndrome	1.59e-05	0.000118	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MTOR—epilepsy syndrome	1.59e-05	0.000117	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—RELA—epilepsy syndrome	1.58e-05	0.000117	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—JUN—epilepsy syndrome	1.55e-05	0.000115	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MTOR—epilepsy syndrome	1.55e-05	0.000114	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—S100B—epilepsy syndrome	1.53e-05	0.000113	CbGpPWpGaD
Vardenafil—PDE1B—Disease—IL6ST—epilepsy syndrome	1.52e-05	0.000112	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SOCS3—epilepsy syndrome	1.52e-05	0.000112	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CDC42—epilepsy syndrome	1.51e-05	0.000112	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—TXNRD1—epilepsy syndrome	1.51e-05	0.000112	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—FOS—epilepsy syndrome	1.51e-05	0.000112	CbGpPWpGaD
Vardenafil—PDE1B—Disease—NOS2—epilepsy syndrome	1.51e-05	0.000111	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MMP9—epilepsy syndrome	1.51e-05	0.000111	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.49e-05	0.00011	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.49e-05	0.00011	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.49e-05	0.00011	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.49e-05	0.00011	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.49e-05	0.00011	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.49e-05	0.00011	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CASP8—epilepsy syndrome	1.47e-05	0.000109	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—AQP1—epilepsy syndrome	1.47e-05	0.000109	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AVP—epilepsy syndrome	1.46e-05	0.000108	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—AKT1—epilepsy syndrome	1.46e-05	0.000108	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CASP3—epilepsy syndrome	1.46e-05	0.000108	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.43e-05	0.000106	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CASP3—epilepsy syndrome	1.42e-05	0.000105	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—JUN—epilepsy syndrome	1.42e-05	0.000105	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—SRC—epilepsy syndrome	1.39e-05	0.000103	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HES1—epilepsy syndrome	1.38e-05	0.000102	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—JUN—epilepsy syndrome	1.38e-05	0.000102	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MMP9—epilepsy syndrome	1.38e-05	0.000102	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.36e-05	0.000101	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.36e-05	0.000101	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.36e-05	0.000101	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.36e-05	0.000101	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—VEGFA—epilepsy syndrome	1.35e-05	0.0001	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FYN—epilepsy syndrome	1.35e-05	9.96e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MMP9—epilepsy syndrome	1.34e-05	9.94e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—H2AFX—epilepsy syndrome	1.34e-05	9.92e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MEF2C—epilepsy syndrome	1.34e-05	9.91e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—FGF2—epilepsy syndrome	1.33e-05	9.84e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CHRM3—epilepsy syndrome	1.33e-05	9.82e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—KCNJ11—epilepsy syndrome	1.33e-05	9.82e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—AKT1—epilepsy syndrome	1.3e-05	9.64e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—YWHAZ—epilepsy syndrome	1.29e-05	9.57e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NGF—epilepsy syndrome	1.28e-05	9.47e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—SRC—epilepsy syndrome	1.27e-05	9.4e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.26e-05	9.35e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.26e-05	9.35e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—BCL2—epilepsy syndrome	1.26e-05	9.35e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.26e-05	9.32e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCR5—epilepsy syndrome	1.24e-05	9.21e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—SRC—epilepsy syndrome	1.24e-05	9.16e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—VEGFA—epilepsy syndrome	1.24e-05	9.16e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—RELA—epilepsy syndrome	1.24e-05	9.14e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—FGF2—epilepsy syndrome	1.23e-05	9.09e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HTR2A—epilepsy syndrome	1.22e-05	9.01e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MTOR—epilepsy syndrome	1.21e-05	8.96e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—VEGFA—epilepsy syndrome	1.21e-05	8.92e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.19e-05	8.79e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TSC2—epilepsy syndrome	1.16e-05	8.56e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AGT—epilepsy syndrome	1.16e-05	8.55e-05	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—AKT1—epilepsy syndrome	1.15e-05	8.51e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—APOE—epilepsy syndrome	1.13e-05	8.38e-05	CbGpPWpGaD
Vardenafil—PDE6G—Disease—AKT1—epilepsy syndrome	1.13e-05	8.34e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.13e-05	8.33e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.13e-05	8.33e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.13e-05	8.33e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.13e-05	8.33e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.13e-05	8.33e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MTOR—epilepsy syndrome	1.12e-05	8.27e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL1B—epilepsy syndrome	1.12e-05	8.26e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—KDR—epilepsy syndrome	1.11e-05	8.21e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PTGS2—epilepsy syndrome	1.11e-05	8.2e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—JUN—epilepsy syndrome	1.08e-05	8.01e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	1.08e-05	8e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PRKCB—epilepsy syndrome	1.07e-05	7.9e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL6ST—epilepsy syndrome	1.06e-05	7.87e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	1.05e-05	7.8e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	1.05e-05	7.75e-05	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—AKT1—epilepsy syndrome	1.04e-05	7.66e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.03e-05	7.62e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.03e-05	7.62e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.03e-05	7.62e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	9.91e-06	7.33e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—POMC—epilepsy syndrome	9.73e-06	7.2e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—SRC—epilepsy syndrome	9.71e-06	7.18e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	9.57e-06	7.08e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GBE1—epilepsy syndrome	9.57e-06	7.08e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCL2—epilepsy syndrome	9.52e-06	7.04e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	9.46e-06	7e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	9e-06	6.66e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	9e-06	6.66e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—BCHE—epilepsy syndrome	8.96e-06	6.63e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—SRC—epilepsy syndrome	8.96e-06	6.63e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	8.76e-06	6.48e-05	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—AKT1—epilepsy syndrome	8.63e-06	6.39e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—FGF2—epilepsy syndrome	8.6e-06	6.36e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	8.55e-06	6.33e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NT5E—epilepsy syndrome	8.53e-06	6.31e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ALAD—epilepsy syndrome	8.53e-06	6.31e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	8.46e-06	6.26e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—TH—epilepsy syndrome	8.43e-06	6.24e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	8.14e-06	6.02e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	8.14e-06	6.02e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—RELA—epilepsy syndrome	7.99e-06	5.91e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	7.97e-06	5.89e-05	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—AKT1—epilepsy syndrome	7.9e-06	5.84e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MTOR—epilepsy syndrome	7.83e-06	5.79e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ADSL—epilepsy syndrome	7.81e-06	5.77e-05	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—AKT1—epilepsy syndrome	7.69e-06	5.69e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GLUL—epilepsy syndrome	7.65e-06	5.66e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	7.51e-06	5.56e-05	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—AKT1—epilepsy syndrome	7.27e-06	5.38e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CASP3—epilepsy syndrome	7.2e-06	5.33e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	7.03e-06	5.2e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	7.03e-06	5.2e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—JUN—epilepsy syndrome	7e-06	5.18e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CAT—epilepsy syndrome	6.94e-06	5.14e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AQP1—epilepsy syndrome	6.82e-06	5.05e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MMP9—epilepsy syndrome	6.81e-06	5.04e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	6.75e-06	5e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—AKT1—epilepsy syndrome	6.6e-06	4.88e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GPX1—epilepsy syndrome	6.28e-06	4.64e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SRC—epilepsy syndrome	6.28e-06	4.64e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	6.17e-06	4.56e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	6.17e-06	4.56e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—VEGFA—epilepsy syndrome	6.11e-06	4.52e-05	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—AKT1—epilepsy syndrome	6.03e-06	4.46e-05	CbGpPWpGaD
Vardenafil—PDE1B—Disease—AKT1—epilepsy syndrome	5.57e-06	4.12e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—AGT—epilepsy syndrome	5.5e-06	4.07e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—APOE—epilepsy syndrome	5.39e-06	3.99e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	5.03e-06	3.72e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	4.9e-06	3.63e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	4.87e-06	3.6e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—POMC—epilepsy syndrome	4.63e-06	3.43e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	4.4e-06	3.25e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ALB—epilepsy syndrome	4.22e-06	3.12e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	4.19e-06	3.1e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—BCHE—epilepsy syndrome	4.17e-06	3.08e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	3.98e-06	2.94e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	3.93e-06	2.91e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—TH—epilepsy syndrome	3.92e-06	2.9e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AKT1—epilepsy syndrome	3.9e-06	2.89e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	3.7e-06	2.73e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	3.27e-06	2.42e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CAT—epilepsy syndrome	3.23e-06	2.39e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	3.14e-06	2.32e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.92e-06	2.16e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.56e-06	1.89e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.51e-06	1.85e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—POMC—epilepsy syndrome	2.15e-06	1.59e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.96e-06	1.45e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—AKT1—epilepsy syndrome	1.86e-06	1.37e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.72e-06	1.27e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AKT1—epilepsy syndrome	8.63e-07	6.39e-06	CbGpPWpGaD
